These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Salpeter SR; Wall AJ; Buckley NS Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343 [TBL] [Abstract][Full Text] [Related]
25. Controlling asthma. Highlights of the 1999 Canadian Asthma Consensus Report. D'Urzo AD Can Fam Physician; 2000 Apr; 46():895-8, 902-4. PubMed ID: 10790822 [No Abstract] [Full Text] [Related]
26. How our treatment of asthma has changed in the last half century. Nelson HS Ann Allergy Asthma Immunol; 2021 Nov; 127(5):518-519. PubMed ID: 34022389 [No Abstract] [Full Text] [Related]
27. beta-Adrenoceptor inverse agonists in asthma. Dickey BF; Walker JK; Hanania NA; Bond RA Curr Opin Pharmacol; 2010 Jun; 10(3):254-9. PubMed ID: 20399707 [TBL] [Abstract][Full Text] [Related]
28. Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients. Asano K; Yamada-Yamasawa W; Kudoh H; Matsuzaki T; Nakajima T; Hakuno H; Hiraoka R; Fukunaga K; Oguma T; Sayama K; Yamaguchi K; Nagabukuro A; Harada Y; Ishizaka A Respirology; 2010 Jul; 15(5):849-54. PubMed ID: 20546196 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in the treatment of asthma. Donohue JF Curr Opin Pulm Med; 1996 Jan; 2(1):1-6. PubMed ID: 9363108 [No Abstract] [Full Text] [Related]
30. Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Ortega VE; Peters SP Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285 [TBL] [Abstract][Full Text] [Related]
31. Long- versus short-acting beta 2-agonists. Implications for drug therapy. Boulet LP Drugs; 1994 Feb; 47(2):207-22. PubMed ID: 7512898 [No Abstract] [Full Text] [Related]
32. Drugs for asthma. Treat Guidel Med Lett; 2008 Dec; 6(76):83-90. PubMed ID: 19029869 [No Abstract] [Full Text] [Related]
33. Safety of long-acting β agonists for the treatment of asthma: clearing the air. Rodrigo GJ; Castro-Rodríguez JA Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma']. Diamant Z; Dekhuijzen PN Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539 [TBL] [Abstract][Full Text] [Related]
36. Asthma in children. Keeley D Clin Evid; 2002 Jun; (7):244-61. PubMed ID: 12230648 [No Abstract] [Full Text] [Related]
37. Regular beta-agonist therapy--the quality of the evidence. Sears MR; Taylor DR Eur Respir J; 1992 Jul; 5(7):896-7, author reply 898-900. PubMed ID: 1354171 [No Abstract] [Full Text] [Related]
38. How pharmacogenomics will play a role in the management of asthma. Wechsler ME; Israel E Am J Respir Crit Care Med; 2005 Jul; 172(1):12-8. PubMed ID: 15778484 [No Abstract] [Full Text] [Related]
39. [AIRE Study: diminished quality of life is the rule in asthma. Optimally controllable, still badly controlled]. MMW Fortschr Med; 2001 Jun; 143(24):56-7. PubMed ID: 11469023 [No Abstract] [Full Text] [Related]